{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T14:56:29Z","timestamp":1726412189181},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1987,7,1]],"date-time":"1987-07-01T00:00:00Z","timestamp":552096000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drug Ther"],"published-print":{"date-parts":[[1987,7]]},"DOI":"10.1007\/bf02209082","type":"journal-article","created":{"date-parts":[[2005,10,5]],"date-time":"2005-10-05T18:04:37Z","timestamp":1128535477000},"page":"403-409","source":"Crossref","is-referenced-by-count":3,"title":["Calcium antagonists\u2014Adverse drug interactions"],"prefix":"10.1007","volume":"1","author":[{"given":"H.","family":"Reicher-Reiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. N.","family":"Neufeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. X.","family":"Ebner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02209082_CR1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/bmj.282.6260.288","volume":"282","author":"JK Aronson","year":"1981","unstructured":"Aronson JK, Graham-Smith DG. Clinical pharmacology. Adverse drug interactions.Br Med J 1981;282:288.","journal-title":"Br Med J"},{"key":"BF02209082_CR2","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/0002-9149(82)91251-6","volume":"50","author":"HO Klein","year":"1982","unstructured":"Klein HO, Kaplinsky E. Verapamil and digoxin: Their respective effects on atrial fibrillation and their interaction.Am J Cardiol 1982;50:894.","journal-title":"Am J Cardiol"},{"issue":"5","key":"BF02209082_CR3","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/01.CIR.65.5.998","volume":"65","author":"HO Klein","year":"1982","unstructured":"Klein HO, Lang R, Weiss E, et al. The influence of verapamil on serum digoxin concentration.Circulation 1982;65(5):998.","journal-title":"Circulation"},{"key":"BF02209082_CR4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00542456","volume":"22","author":"KE Pedersen","year":"1982","unstructured":"Pedersen KE, Pedersen AD, Klitgaard NA, et al. The longterm effect of verapamil on plasma digoxin concentration and renal digoxin clearance in healthy subjects.Eur J Clin Pharmacol 1982;22:123.","journal-title":"Eur J Clin Pharmacol"},{"key":"BF02209082_CR5","first-page":"501A","volume":"29","author":"JB Schwartz","year":"1981","unstructured":"Schwartz JB, Keefe D, Kates RE, et al. Verapamil and digoxin: another drug interaction.Clin Res 1981;29:501A.","journal-title":"Clin Res"},{"key":"BF02209082_CR6","unstructured":"Schwartz JB, Keefe D, Kates RE, et al. Acute and chronic pharmacodynamic interaction of verapamil and digoxin in atrial fibrillation."},{"key":"BF02209082_CR7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1742-1241.1980.tb07696.x","volume":"34","author":"NG Kounis","year":"1980","unstructured":"Kounis NG. Asystole after verapamil and digoxin.Br J Clin Prac 1980;34:7.","journal-title":"Br J Clin Prac"},{"key":"BF02209082_CR8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/0002-8703(84)90635-5","volume":"108","author":"J Zatuchni","year":"1984","unstructured":"Zatuchni J. Verapamil-digoxin interaction.Am Heart J 1984;108:412.","journal-title":"Am Heart J"},{"key":"BF02209082_CR9","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0002-8703(85)90021-3","volume":"110","author":"J Kuhlmann","year":"1985","unstructured":"Kuhlmann J, Marcin S. Effects of verapamil on pharmacokinetics and pharmacodynamics of digitoxin in patients.Am Heart J 1985;110:1245.","journal-title":"Am Heart J"},{"key":"BF02209082_CR10","first-page":"699","volume":"107","author":"JB Schwartz","year":"1984","unstructured":"Schwartz JB, Raizner A, Akers S. The effect of nifedipine on serum digoxin concentrations in patients.Am Heart J 1984;107:699.","journal-title":"Am Heart J"},{"key":"BF02209082_CR11","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/clpt.1982.203","volume":"32","author":"KE Pedersen","year":"1982","unstructured":"Pedersen KE, Pedersen AD, Klitgaard NA, et al. Effects of nifedipine on digoxin kinetics in healthy subjects.Clin Pharmacol Ther 1982;32:562.","journal-title":"Clin Pharmacol Ther"},{"key":"BF02209082_CR12","unstructured":"DeCesaris R, Balestrazzi M, Ranieri G, et al. Nifedipinedigoxin interaction. Study by 86 rubidium method. In: Fondazione G, ed.Calcium antagonists to calcium entry blockers. Abstract Book, Clini Venedig, 1982;578:RIA."},{"key":"BF02209082_CR13","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0140-6736(81)92727-6","volume":"I","author":"GG Belz","year":"1981","unstructured":"Belz GG, Aust PE, Munkes R. Digoxin plasma concentrations and nifedipine.Lancet 1981;I:844.","journal-title":"Lancet"},{"key":"BF02209082_CR14","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0002-9149(84)91653-9","volume":"53","author":"Y Oyama","year":"1984","unstructured":"Oyama Y, Fujii S, Kanda K, et al. Digoxin-diltiazem interaction.Am J Cardiol 1984;53:1480.","journal-title":"Am J Cardiol"},{"key":"BF02209082_CR15","first-page":"419","volume":"5","author":"U Elkayam","year":"1985","unstructured":"Elkayam U, Parikh K, Torkan B, et al. Absence of effect of diltiazem on digoxin serum concentration and renal clearance in patients with cardiac disease (abstract).JACC 1985;5:419.","journal-title":"JACC"},{"key":"BF02209082_CR16","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/01.CIR.65.4.660","volume":"65","author":"M Packer","year":"1982","unstructured":"Packer M, Meller J, Medina N, et al. Hemodynamic consequences of combined beta-adrenergic and slow calcium channel blockade in man.Circulation 1982;65:660.","journal-title":"Circulation"},{"key":"BF02209082_CR17","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/0002-9149(81)90194-6","volume":"47","author":"CYC Chew","year":"1981","unstructured":"Chew CYC, Hecht HS, Collett JT, et al. Influence of the severity of ventricular dysfunction on the hemodynamic responses to intravenously administered verapamil in ischemic heart disease.Am J Cardiol 1981;47:917.","journal-title":"Am J Cardiol"},{"key":"BF02209082_CR18","series-title":"Asia-Pacific Adalat Symposium","volume-title":"New therapy of ischemic heart disease and hypertension","author":"H Reicher-Reiss","year":"1983","unstructured":"Reicher-Reiss H, Motro M, Neufeld HN. Efficacy of nifedipine, beta-blockers or their combination in stable angina pectoris. In: Hashimoto K, Kawai C, eds.New therapy of ischemic heart disease and hypertension. Asia-Pacific Adalat Symposium. Tokyo: Medical Tribune Inc., 1983."},{"key":"BF02209082_CR19","series-title":"Fifth International Symposium","first-page":"328","volume-title":"New therapy of ischemic heart disease and hypertension","author":"F Ebner","year":"1983","unstructured":"Ebner F. Administration of nifedipine to patients treated with digitalis glycosides, anti-diabetic agents and beta-blockers. In: Kaltenbach M, Neufeld HN, eds.New therapy of ischemic heart disease and hypertension. Fifth International Symposium. Amsterdam: Excerpta Medica, 1983. Pp.328."},{"key":"BF02209082_CR20","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1136\/bmj.281.6253.1462","volume":"281","author":"LH Opie","year":"1980","unstructured":"Opie LH, White DA. Adverse interaction between nifedipine and beta blockade.Br Med J 1980;281:1462.","journal-title":"Br Med J"},{"key":"BF02209082_CR21","first-page":"482","volume":"3","author":"J Kenny","year":"1984","unstructured":"Kenny J, Kiff P, Holmes J. The beneficial effect of combined diltiazem and propranolol treatment in effort-related angina pectoris (abstract).JACC 1984;3:482.","journal-title":"JACC"},{"key":"BF02209082_CR22","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/01.CIR.68.3.560","volume":"68","author":"J Hung","year":"1983","unstructured":"Hung J, Lamb IH, Connolly SJ, et al. The effect of diltiazem and propranolol, alone and in combination, on exercise performance and left ventricular function in patients with stable effort angina: a double-blind randomized and placebo controlled study.Circulation 1983;68:560.","journal-title":"Circulation"},{"key":"BF02209082_CR23","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0002-9149(83)90113-3","volume":"52","author":"PY Tilmant","year":"1983","unstructured":"Tilmant PY, Lablanche JM, Thieudeux FA, et al. Detrimental effect of propranolol in patients with coronary arterial spasm countered by combination with diltiazem.Am J Cardiol 1983;52:230.","journal-title":"Am J Cardiol"},{"key":"BF02209082_CR24","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0735-1097(83)80033-3","volume":"1","author":"LS Dreifus","year":"1983","unstructured":"Dreifus LS, Michelson EL. Adverse combined effects of diltiazem plus propranolol on atrioventricular nodal refractory periods and conduction in the rabbit heart.JACC 1983;1:680.","journal-title":"JACC"},{"key":"BF02209082_CR25","first-page":"481A","volume":"32","author":"AA Maisel","year":"1984","unstructured":"Maisel AA, Motulsky JH, Insel PA. Hypotension after guinidine plus verapamil: A pharmacodynamic interaction at alpha-adrenergic receptors.Clin Res 1984;32:481A.","journal-title":"Clin Res"},{"key":"BF02209082_CR26","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/01.CIR.64.3.437","volume":"64","author":"SE Epstein","year":"1981","unstructured":"Epstein SE, Rosing DR. Verapamil: its potential for causing serious complications in patients with hypertrophie cardiomyopathy.Circulation 1981;64:437.","journal-title":"Circulation"},{"key":"BF02209082_CR27","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/0002-8703(84)90717-8","volume":"108","author":"JA Farringer","year":"1984","unstructured":"Farringer JA, Green JA, O'Rourke RA, et al. Nifedipineinduced alterations in serum quinidine concentrations.Am Heart J 1984;108:1570.","journal-title":"Am Heart J"},{"key":"BF02209082_CR28","first-page":"461","volume":"2","author":"JA Green","year":"1983","unstructured":"Green JA, Clementi WA, Porter C, et al. Nifedipine-quinidine interaction.Clin Pharm 1983;2:461.","journal-title":"Clin Pharm"},{"key":"BF02209082_CR29","first-page":"1581","volume":"3","author":"A Saeed","year":"1984","unstructured":"Saeed A. Nifedipine-phenytoin Interaction.JACC 1984;3:1581.","journal-title":"JACC"},{"key":"BF02209082_CR30","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0140-6736(78)90103-4","volume":"I","author":"D Ross","year":"1978","unstructured":"Ross D, Vohra J, Sloman JG. Disopyramide in myocardial infarction.Lancet 1978;I:330.","journal-title":"Lancet"},{"key":"BF02209082_CR31","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0140-6736(78)90594-9","volume":"I","author":"PH Kidner","year":"1978","unstructured":"Kidner PH, Besterman EM. Disopyramide in myocardial infarction.Lancet 1978;I:562.","journal-title":"Lancet"},{"key":"BF02209082_CR32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0002-8703(85)90431-4","volume":"109","author":"TH Lee","year":"1985","unstructured":"Lee TH, Freidman PL, Goldman L, et al. Sinus arrest and hypotension with combined amiodarone-diltiazem therapy.Am Heart J 1985;109:163.","journal-title":"Am Heart J"},{"key":"BF02209082_CR33","unstructured":"Hantler CB, Clifford BD, Kroll DA, et al. Verapamil does have prolonged interactions with halothane. ASA abstracts."},{"key":"BF02209082_CR34","doi-asserted-by":"crossref","unstructured":"Spiss CK, Windelmayer-Goettel M, Zadrobilek E, et al. Nifedipine-induced hypertension in man: Haemodynamic response during isoflurane and halothane anesthesia. Presented at European Congress for Anesthesia, Graz, 1985.","DOI":"10.1097\/00000542-198509001-00093"},{"key":"BF02209082_CR35","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/00000542-198310000-00021","volume":"59","author":"K Skarvan","year":"1983","unstructured":"Skarvan K. Preoperative nifedipine treatment and anesthesia in patients with coronary artery disease.Anesthesiology 1983;59:362.","journal-title":"Anesthesiology"},{"key":"BF02209082_CR36","first-page":"804","volume":"57","author":"JG Bovill","year":"1984","unstructured":"Bovill JG, Wezel V, Schuller J, et al. Comparison of nitroglycerin, verapamil and nifedipine in coronary artery surgery.Br J Anesth 1984;57:804.","journal-title":"Br J Anesth"},{"key":"BF02209082_CR37","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/01.CIR.61.5.913","volume":"61","author":"MD Guazzi","year":"1981","unstructured":"Guazzi MD, Fiorentini C, Olivari MT, et al. Short- and longterm efficacy of a calcium-antagonist agent (nifedipine) combined with methyldopa in the treatment of severe hypertension.Circulation 1981;61:913.","journal-title":"Circulation"},{"key":"BF02209082_CR38","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/thx.39.8.576","volume":"39","author":"AML Lever","year":"1984","unstructured":"Lever AML, Corris PA, Gibso GJ. Nifedipine enhances the bronchodilator effect of salbutamol.Thorax 1984;39:576.","journal-title":"Thorax"},{"key":"BF02209082_CR39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1398-9995.1984.tb01928.x","volume":"39","author":"K Svedmyr","year":"1984","unstructured":"Svedmyr K, Loefdahl CG, Svedmyr N. Bifedipine\u2014a calcium channel blocker\u2014in asthmatic patients. Interaction with terbutaline.Allergy 1984;39:17.","journal-title":"Allergy"},{"key":"BF02209082_CR40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.0954-6820.1981.tb09771.x","volume":"210","author":"DEH Andersson","year":"1981","unstructured":"Andersson DEH, Rojdmark S. Improvement of glucose tolerance by verapamil in patients with non-insulin dependent diabetes mellitus.Acta Med Scand 1981;210:27.","journal-title":"Acta Med Scand"},{"key":"BF02209082_CR41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/bmj.283.6283.19","volume":"283","author":"S Charles","year":"1981","unstructured":"Charles S, Ketelslegers JM, Buysschaert M, et al. Hyperglycaemic effect of nifedipine.Br Med J 1981;283:19.","journal-title":"Br Med J"},{"key":"BF02209082_CR42","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF00636791","volume":"18","author":"D Giugliano","year":"1980","unstructured":"Giugliano D, Torella R, Cacciapuoti F, et al. Impairment of insulin secretion in man by nifedipine.Eur J Clin Pharmacol 1980;18:395.","journal-title":"Eur J Clin Pharmacol"},{"key":"BF02209082_CR43","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/00005344-198309000-00022","volume":"5","author":"SW Rabkin","year":"1983","unstructured":"Rabkin SW. Interaction of external calcium concentration and verapamil on the effects of doxorubicin (adriamycin) in the isolated heart preparation.J Cardiovasc Pharmacol 1983;5:848.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF02209082_CR44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/cvr\/17.1.43","volume":"17","author":"J Wikman-Coffeit","year":"1983","unstructured":"Wikman-Coffeit J, Rapcsork M, Sievers R, Ronleau JL, Parmley WW. Verapamil, propranolol, and hydralazine protect against the acute cardiac depression induced by adriamycin.Cardiovasc Res 1983;17:43\u201349.","journal-title":"Cardiovasc Res"},{"key":"BF02209082_CR45","first-page":"458","volume":"2","author":"TG Burnakis","year":"1983","unstructured":"Burnakis TG, Seldon M, Czaplicki AD. Increased serum theophylline concentrations secondary to oral verapamil.Clin Pharmacol 1983;2:458.","journal-title":"Clin Pharmacol"},{"key":"BF02209082_CR46","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/0002-8703(84)90776-2","volume":"108","author":"LA Weinrauch","year":"1984","unstructured":"Weinrauch LA, Belok S, D'Elia JA. Decreased serum lithium during verapamil therapy.Am Heart J 1984;108:1378.","journal-title":"Am Heart J"},{"key":"BF02209082_CR47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/00003088-198207010-00002","volume":"7","author":"A Somogyi","year":"1982","unstructured":"Somogyi A, Gugler R. Drug interaction with cimetidine.Clin Pharmacokinetics 1982;7:23.","journal-title":"Clin Pharmacokinetics"},{"key":"BF02209082_CR48","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/clpt.1984.218","volume":"36","author":"MC Smith MS<Benyunes","year":"1984","unstructured":"Smith MS<Benyunes MC, Bjornsson TD, et al. Influence of cimetidine on verapamil kinetics and dynamics.Clin Pharmacol Ther 1984;36:551.","journal-title":"Clin Pharmacol Ther"},{"key":"BF02209082_CR49","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1055\/s-2008-1069821","volume":"108","author":"P Dylewicz","year":"1983","unstructured":"Dylewicz P, Kirch W, Benesh L, et al. Influence of nifedipine with and without cimetidine on exercise tolerance in patients rehabilitated after myocardial infarction.Dtsch med Wschr 1983;108:1757.","journal-title":"Dtsch med Wschr"},{"key":"BF02209082_CR50","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/01.CIR.68.3.628","volume":"68","author":"CB Higgins","year":"1983","unstructured":"Higgins CB, Kuber M, Slutsky RA. Interaction between verapamil and contrast media in coronary angiography. Comparison of standard ionic and new nonionic media.Circulation 1983;68:628.","journal-title":"Circulation"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02209082.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02209082\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02209082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T10:30:30Z","timestamp":1706610630000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02209082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,7]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1987,7]]}},"alternative-id":["BF02209082"],"URL":"https:\/\/doi.org\/10.1007\/bf02209082","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"type":"print","value":"0920-3206"},{"type":"electronic","value":"1573-7241"}],"subject":[],"published":{"date-parts":[[1987,7]]}}}